Tissue Regenix Group PLC

Tissue Regenix Group PLC, also known by the ticker TRXG PLC, is a UK-based medical technology company.
The company's name includes "Tissue Regenix", indicating a focus on tissue regeneration technologies.
It maintains operations in the United Kingdom.
Additionally, it operates an American manufacturing plant.

On January 28, 2020, the company experienced unauthorized access to its computer systems and a third-party IT provider in the United States.
This breach prompted the temporary shutdown of its American manufacturing plant.
In response, the company took the affected systems offline.
It engaged forensic cybersecurity specialists and legal authorities to investigate the incident.
The breach did not impact the company's UK operations or its financial systems.
The incident resulted in a significant decline in the company's share price.

The cyberattack occurred amid pre-existing concerns about the firm's funding stability beyond April.
As a public limited company (PLC), Tissue Regenix Group PLC is subject to the regulatory requirements applicable to such entities.
The company's structure as a group suggests it may comprise parent and subsidiary entities.
Its transatlantic footprint, with facilities in both the UK and the US, distinguishes it from purely domestic peers.
The segmentation of its IT environment, whereby UK systems remained isolated from the US breach, highlights a notable aspect of its operational architecture.